Literature DB >> 17886451

Synthetic osteopontin-derived peptide SVVYGLR can induce neovascularization in artificial bone marrow scaffold biomaterials.

Yoshinosuke Hamada1, Hiroshi Egusa, Yoshitosi Kaneda, Isao Hirata, Naomasa Kawaguchi, Takafumi Hirao, Takuya Matsumoto, Makiko Yao, Kiyoshi Daito, Mayuka Suzuki, Hirofumi Yatani, Michiharu Daito, Masayuki Okazaki, Nariaki Matsuura.   

Abstract

We have previously reported that an osteopontin-derived SVVYGLR peptide exhibited potent angiogenic activity in vitro and in vivo. In the present study, the focus points were on the in vitro effect of SVVYGLR on bone marrow stromal cell proliferation, as well as its in vivo effect on bone tissue formation when grafts made of CO3Ap-collagen sponge- as a scaffold biomaterial containing the SVVYGLR motif - were implanted. SVVYGLR peptide promoted bone marrow stromal cell proliferation. When a CO3Ap-collagen sponge containing SVVYGLR peptide was implanted as a graft into a tissue defect created in rat tibia, the migration of numerous vascular endothelial cells - as well as prominent angiogenesis - inside the graft could be detected after one week. These results thus suggested that our scaffold biomaterials including the peptide could be useful for bone tissue regeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17886451     DOI: 10.4012/dmj.26.487

Source DB:  PubMed          Journal:  Dent Mater J        ISSN: 0287-4547            Impact factor:   2.102


  14 in total

1.  SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis.

Authors:  Ayako Uchinaka; Yoshinosuke Hamada; Seiji Mori; Shigeru Miyagawa; Atsuhiro Saito; Yoshiki Sawa; Nariaki Matsuura; Hirofumi Yamamoto; Naomasa Kawaguchi
Journal:  Mol Cell Biochem       Date:  2015-06-27       Impact factor: 3.396

2.  Effect of grafting BMP2-derived peptide to nanoparticles on osteogenic and vasculogenic expression of stromal cells.

Authors:  Angel E Mercado; Xiaoming Yang; Xuezhong He; Esmaiel Jabbari
Journal:  J Tissue Eng Regen Med       Date:  2012-07-05       Impact factor: 3.963

Review 3.  Endothelialized biomaterials for tissue engineering applications in vivo.

Authors:  Omar F Khan; Michael V Sefton
Journal:  Trends Biotechnol       Date:  2011-05-05       Impact factor: 19.536

4.  Controlled spatial and conformational display of immobilised bone morphogenetic protein-2 and osteopontin signalling motifs regulates osteoblast adhesion and differentiation in vitro.

Authors:  Elizabeth A Mitchell; Benjamin T Chaffey; Andrew W McCaskie; Jeremy H Lakey; Mark A Birch
Journal:  BMC Biol       Date:  2010-05-10       Impact factor: 7.431

5.  Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly(lactide-co-glycolide fumarate) nanoparticles.

Authors:  Angel E Mercado; Junyu Ma; Xuezhong He; Esmaiel Jabbari
Journal:  J Control Release       Date:  2009-08-20       Impact factor: 9.776

6.  Geometrical microfeature cues for directing tubulogenesis of endothelial cells.

Authors:  Yifeng Lei; Omar F Zouani; Murielle Rémy; Cédric Ayela; Marie-Christine Durrieu
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

Review 7.  The role of peptides in bone healing and regeneration: a systematic review.

Authors:  Ippokratis Pountos; Michalis Panteli; Anastasios Lampropoulos; Elena Jones; Giorgio Maria Calori; Peter V Giannoudis
Journal:  BMC Med       Date:  2016-07-11       Impact factor: 8.775

8.  The role of osteopontin in inflammatory processes.

Authors:  Susan Amanda Lund; Cecilia M Giachelli; Marta Scatena
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

9.  Suppression of tumour growth by orally administered osteopontin is accompanied by alterations in tumour blood vessels.

Authors:  S R Rittling; P L Wejse; K Yagiz; G A Warot; T Hui
Journal:  Br J Cancer       Date:  2014-01-28       Impact factor: 7.640

10.  Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms.

Authors:  Takao Watamoto; Hiroshi Egusa; Takashi Sawase; Hirofumi Yatani
Journal:  Front Microbiol       Date:  2015-12-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.